Nicolette (Nikki) J. Sullivan, Ph.D.

1998-2002 Psychology, Neuroscience Miami University (Ohio), Oxford, OH 
 2006-2007 Social Sciences University of Chicago, Chicago, IL 
 2010-2015 Computation and Neural Systems California Institute of Technology, Pasadena, CA 
 2015-2019 Psychology and Neuroscience Duke University, Durham, NC 
 2019- Management, Marketing London School of Economics, London, England, United Kingdom 
"Nicolette (Nikki) Sullivan"
Mean distance: 15.45 (cluster 23)


Sign in to add mentor
Antonio Rangel grad student 2010- Caltech
Howard Charles Nusbaum grad student 2006-2007 Chicago
Scott Huettel post-doc 2015- Duke
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Corti D, Misasi J, Mulangu S, et al. (2016) Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science (New York, N.Y.)
Misasi J, Gilman MS, Kanekiyo M, et al. (2016) Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science (New York, N.Y.)
De Santis O, Audran R, Pothin E, et al. (2015) Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. The Lancet. Infectious Diseases
Ledgerwood JE, Sullivan NJ, Graham BS. (2015) Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report. The New England Journal of Medicine. 373: 776
Zhou Y, Sullivan NJ. (2015) Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine. Current Opinion in Immunology. 35: 131-6
Regules JA, Beigel JH, Paolino KM, et al. (2015) A Recombinant Vesicular Stomatitis Virus Ebola Vaccine - Preliminary Report. The New England Journal of Medicine
Rampling T, Ewer K, Bowyer G, et al. (2015) A Monovalent Chimpanzee Adenovirus Ebola Vaccine - Preliminary Report. The New England Journal of Medicine
Kibuuka H, Berkowitz NM, Millard M, et al. (2015) Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet (London, England). 385: 1545-54
Sullivan N, Hutcherson C, Harris A, et al. (2015) Dietary self-control is related to the speed with which attributes of healthfulness and tastiness are processed. Psychological Science. 26: 122-34
Sarwar UN, Costner P, Enama ME, et al. (2015) Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial. The Journal of Infectious Diseases. 211: 549-57
See more...